trial · primary record
Active PRA-216
Atopic Dermatitis (AD)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 39 |
| Primary completion | 2028-05-16 |
| Primary endpoint | Incidence, nature, and severity of treatment emergent adverse events (TEAEs) and serious adverse events (SAEs) |
| Registry ID | NCT07810777 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:40:50.430Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07810777
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.